Electrotrichogenesis

Electrotrichogenesis (ETG) involves the stimulation of hair follicles on the scalp with the electric charge of an electrostatic field.

Three studies are listed in the PubMed database relating to the technique.

Electrotrichogenesis was approved in Europe with the CE mark, as a medical device. It was also approved by Health Canada and the Australian health office. ^{(December 2010)}

Further reading

Nataloni, Rochelle,

 Electrotherapeutic device improves appearance of thinning hair Full text, 
 Dermatology Times, 
  
 July 1, 2005,

• ,

 Alopecia: unapproved treatments or indications, 
 Clin. Dermatol., 
 2000,
 Vol. 18(Issue: 2),
 pp. 177–86,
 DOI: 10.1016/s0738-081x(99)00108-x,
 PMID: 10742626,.

• Electrotrichogenesis was also approved by KFDA (Korean Food and Drug Administration) http://www.haircell.co.kr/index.php
• Report Dr. Chu (2003) - Imperial College of Science. Technology and Medicine, Hammersmith Hospital . London (UK) http://www.nuhairuk.co.uk/pdf/DrChu'sReport.pdf
• Pilla, Arthur,

 - MECHANISMS AND THERAPEUTIC APPLICATIONS OF TIME-VARYING AND STATIC MAGNETIC FIELDS, 
 Biochimica et Biophysica Acta (BBA) - General Subjects, 
 2006,
 Vol. 1810(Issue: 12),
 pp. 1236–1245,
 DOI: 10.1016/j.bbagen.2011.10.001,
 PMID: 22005645,

External links

• Reuters news info on Current Technology Corporation, a company that offers electrotrichogenesis treatments.

   This article is a dermatology stub. You can help WikiMD by expanding it!